Bivalirudin not superior to heparin in STEMI patients underg

Sweden: A recent study showed no benefit of Bivalirudin versus heparin in patients with STEMI undergoing primary percutaneous coronary intervention (PCI) with radial access and currently recommended...

Related Keywords

Sweden , Uppsala , Uppsala Lan , Swedish , Stefan James , Uppsala University , Department Of Medical Sciences , Development Of Evidence , Bivalirudin Versus Heparin , Modern Antiplatelet Therapy , Swedish Web System , Evidence Based Care , Heart Disease Evaluated According , Recommended Therapies Registry , Medical Sciences , Elevation Myocardial Infarction , Bivalirudin , Heparin , Pci , Istemi , St Segment Elevation , Myocardial Infarction , Mortality , Bleeding , Cardiovascular Disease , Ocvd , Percutaneous Coronary Intervention , Anticoagulants ,